Trials / Terminated
TerminatedNCT03673774
Impedancemetry in Patients Monitored for Pulmonary Hypertension
Prognostic Value of Cardiac Output Measured by Impedancemetry in Patients Monitored for Pulmonary Hypertension
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- University Hospital, Toulouse · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Monocentric cohort study, prospective, evaluating the variability of cardiac output measurement by resting and stress impedancemetry as a prognostic factor for Pulmonary Hypertension
Detailed description
Cardiac impedancemetry is a technique that allows an electrical representation of cardiac flows. To do this, 6 electrodes are applied to the thorax and a low intensity and high frequency electrical current is transmitted. The impedance is recorded and the variations of the impedance represent the changes in intra-thoracic volume and thus the volume of systolic ejection. This measurement can be done at rest but also during exercise during the walking test. A test of the NO / CO coupled transfer measurement is also performed. The devices that will be used in this project are the Physio-Flow® system and Masterscreen NO / CO coupled transfer measurement device
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | cardiac impedancemetry | The cardiac output is measured by impedance measurement at rest and during the walking test. |
Timeline
- Start date
- 2017-08-23
- Primary completion
- 2021-01-01
- Completion
- 2021-01-01
- First posted
- 2018-09-17
- Last updated
- 2023-07-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03673774. Inclusion in this directory is not an endorsement.